Company Information
CIN
Status
Date of Incorporation
30 March 2010
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
29 September 2022
Paid Up Capital
17,327,090
Authorised Capital
50,000,000
Past Directors
Vishwanatham Ambati
Additional Director
over 11 years ago
over 11 years ago
Suman Vijay Ambati
Director
over 15 years ago
over 15 years ago
Vinay Kumar Ambati
Director
over 15 years ago
over 15 years ago
Vijay Kumar Ambati
Director
over 15 years ago
over 15 years ago
Patents
ABSTRACT
“DEUTERATED AROMATIC HYDROCARBON COMPOUNDS AND METHOD FOR SYNTHESIZING THEREOF”
The present invention relates to a compound of formula (I). Most particularly, it relates to deuterated Iodobenzene-d5 and method for synthesizing thereof. The said compound of formula (I) has wide application in chemical ...
ABSTRACT
“A METHOD FOR CONTINUOUS PRODUCTION OF DEUTERATED BENZENE (BENZENE-D6)”
The present invention provides a method for continuous production of deuterated benzene (benzene-d6). The method comprising: (a) contacting benzene with a catalyst at a temperature ranging from 0oC to 100oC for a period ranging from 8...
ABSTRACT
“A PROCESS FOR PREPARING DERIVATIVE(S) OF AMMONIUM PERCHLORATE (ND4ClO4)”
The present invention provides derivative(s) of ammonium perchlorate and preparation method and use thereof. Most particularly, it relates a process for preparing deuterated ammonium perchlorate (ND₄ClO₄). The said process is carri...
ABSTRACT
“A PROCESS FOR MANUFACTURING 5-NITRO-2, 4-DI TERTIARY BUTYL METHYL CARBONATES- D9”
The present invention provides a process for manufacturing compound of formula I. Said process is carried out by (a) a) alkylating a compound of formula 1 in presence of an acid in a solvent to obtain an intermediate compou...
ABSTRACT
“METHOD FOR SYNTHESIZING DEFEROXAMINE AND/OR IT’S SALT”
The present invention provides a method for synthesizing Deferoxamine mesylate salt with improved yield and purity.The said method comprises the steps of: (a) contacting a compound of formula 1 with an acid in a solvent at 0oC to 40oC for perio...
The present invention relates to a compound of formula I or its pharmaceutically acceptable salt. Most particularly, it relates to deuterated compound of formula I and process for making the same. The compound of formula I is represented by:
Wherein R1 to R22 are interpedently selected from hydrogen (H), deut...
ABSTRACT
“METHOD FOR PRODUCING DEUTERATED AMMONIUM DINITRAMIDE (ADN-d4)”
The present invention relates to a method for producing deuterated ammonium dinitramide (ADN-d4). More specifically, the invention concerns a single-step method for producing ADN-d4 from potassium dinitramide (KDN) or guanylurea dinitramide (G...
ABSTRACT
“NOVEL DEUTERIUM-SUBSTITUTED NEFAZODONE ANALOGUE AND PROCESS FOR SYNTHESISING THEREOF”
The present invention provides a novel deuterium-substituted nefazodone analogue. More specifically, it pertains to novel deuterium-enriched analogues of nefazodone (compound of formula I), a phenylpiperazine anti-depres...
ABSTRACT
“DEUTERATED ANALOGUE OF AMFEPRAMONE COMPOUND AND PROCESS FOR SYNTHESISING THE SAME”
The present invention provides deuterated analogues of Amfepramone. Most particularly, it relates to deuterated analogues of Amfepramone compound of formula I and process for synthesising the same. The compound of formul...
ABSTRACT
A PROCESS FOR PREPARING BIS(2,4-DI-TERT-BUTYLPHENYL) HYDROGEN PHOSPHATE-D4
The present invention provides Bis(2,4-di-tert-butylphenyl) hydrogen phosphate-d4. The process is carried out by: (a) contacting 2,4-ditert butyl phenol D2 with a reagent in presence of a base in an inert solvent to obtain Bis(2,4-...
ABSTRACT
“A METHOD FOR SYNTHESISING DEUTERATED ENRICHED TOLUENE”
The present invention provides a method for synthesising deuterated enriched toluene of formula I
wherein R1 to R8 are independently selected from hydrogen (H), deuterium (-D) and combinations thereof. The method is carried out by: (a) contacting ...
ABSTRACT
“DEUTERATED SUFENTANIL AND PROCESS FOR SYNTHESIS THEREOF”
The present invention provides analogue of Sufentanil of compound of formula I and process for synthesising therefore. The compound of formula I is represented by
Wherein R1, R2, R3, R4 are independently selected from hydrogen (H), deuterium (...
Registered Trademarks
[Class : 16] Packaging Material, Boxes Of Cardboard, Packaging Cartons Of Cardboard.
[Class : 16] Packaging Material, Boxes Of Cardboard, Packaging Cartons Of Cardboard
[Class : 42] Pharmaceutical Research And Development, Research And Development In The Pharmaceutical And Biotechnology Fields
View +19 more Brands for Clearsynth Labs Limited.
Charges
21 June 2019
Rbl Bank Limited
3 Crore
11 September 2018
Icici Bank Limited
1 Crore
27 January 2016
Icici Bank Limited
90 Lak
27 January 2016
Icici Bank Limited
1 Crore
27 January 2016
Icici Bank Limited
2 Crore
27 January 2016
Icici Bank Limited
8 Crore
24 January 2015
Axis Bank Limited
3 Crore
26 June 2020
The Federal Bank Ltd
86 Lak
01 August 2019
The Federal Bank Ltd
14 Crore
30 November 2022
Tata Capital Financial Services Limited
38 Lak
28 March 2022
Punjab National Bank
18 Crore
30 November 2022
Tata Capital Financial Services Limited
0
28 March 2022
Others
0
21 June 2019
Others
0
27 January 2016
Others
0
11 September 2018
Others
0
27 January 2016
Others
0
27 January 2016
Others
0
27 January 2016
Others
0
01 August 2019
Others
0
26 June 2020
Others
0
24 January 2015
Axis Bank Limited
0
30 November 2022
Tata Capital Financial Services Limited
0
28 March 2022
Others
0
21 June 2019
Others
0
27 January 2016
Others
0
11 September 2018
Others
0
27 January 2016
Others
0
27 January 2016
Others
0
27 January 2016
Others
0
01 August 2019
Others
0
26 June 2020
Others
0
24 January 2015
Axis Bank Limited
0
30 November 2022
Tata Capital Financial Services Limited
0
28 March 2022
Others
0
21 June 2019
Others
0
27 January 2016
Others
0
11 September 2018
Others
0
27 January 2016
Others
0
27 January 2016
Others
0
27 January 2016
Others
0
01 August 2019
Others
0
26 June 2020
Others
0
24 January 2015
Axis Bank Limited
0
Documents
Form DPT-3-03042021_signed
Form MSME FORM I-31122020_signed
Form MSME FORM I-28122020_signed
Form PAS-6-14122020_signed
Form MGT-14-09102020-signed
Form MGT-14-07102020-signed
Form PAS-3-30092020_signed
Optional Attachment-(1)-30092020
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-30092020
Complete record of private placement offers and acceptances in Form PAS-5.-30092020
Copy of Board or Shareholders? resolution-30092020
Altered memorandum of association-28092020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-28092020
Form MGT-14-24092020-signed
Form MGT-14-21092020-signed
Form DPT-3-19092020-signed
Optional Attachment-(2)-17092020
Altered articles of association-17092020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-17092020
Form PAS-3-11092020_signed
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-11092020
Copy of Board or Shareholders? resolution-11092020
Valuation Report from the valuer, if any;-11092020
Optional Attachment-(1)-11092020
Form SH-7-08092020-signed
Form PAS-6-07092020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-03092020
Altered memorandum of association-03092020
Altered articles of association-03092020
Optional Attachment-(1)-03092020
